Inspired by new advances in peptide-delivered medications, the Raman Lab is exploring peptides’ potential to disrupt certain cancers.
cancer
Researchers Link Mutations in RPA Protein to Cancer, Other Diseases
Researchers in the Lim Lab reveal that dysfunction in a protein essential to maintaining stability in our chromosomes may be responsible for serious diseases.
Screen using blood-based fingerprints for colon cancer shows promise
Scientists at the University of Wisconsin–Madison have identified blood-based fingerprints – human protein markers – associated with the pre-cancerous forms of colon cancer that are most likely to develop into disease. They say their findings are a promising start to what could ultimately lead to a new blood test for the cancer.